Evidence that the tumor-suppressor protein BRCA2 does not regulate cytokinesis in human cells

Journal of Cell Science

Volumn 123, Issue 9, 2010, Pages 1395-1400

  Lekomtsev, Sergey ^a   Guizetti, Julien ^b   Pozniakovsky, Andrei ^c   Gerlich, Daniel W ^b   Petronczki, Mark ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b ETH ZURICH   (Switzerland)

^c MAX PLANCK INSTITUTE OF MOLECULAR CELL BIOLOGY AND GENETICS   (Germany)

Author keywords

BRCA2; Cell division; Chromosomal instability; Cytokinesis; Mitosis

Indexed keywords

BRCA2 PROTEIN; EPITOPE; SMALL INTERFERING RNA; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CARCINOGENESIS; CELL DIVISION; CHROMOSOMAL INSTABILITY; CONTROLLED STUDY; CYTOKINESIS; DNA REPAIR; GENETIC RECOMBINATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MICROSCOPY; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN TARGETING;

BRCA2 PROTEIN; CELL NUCLEUS; CHROMOSOMES, ARTIFICIAL, BACTERIAL; CYTOKINESIS; GENE TARGETING; HELA CELLS; HUMANS; MICROTUBULES; MITOTIC SPINDLE APPARATUS; RAD51 RECOMBINASE; RNA, SMALL INTERFERING; TIME FACTORS; TRANSFECTION;

BACTERIA (MICROORGANISMS);

EID: 77951742673     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.068015     Document Type: Article

References (18)

1. Barr, F. A. and Gruneberg, U. (2007). Cytokinesis: placing and making the final cut. Cell 131, 847-860.
2. Daniels, M. J., Wang, Y., Lee, M. and Venkitaraman, A. R. (2004). Abnormal cytokinesis in cells deficient in the breast cancer susceptibility protein BRCA2. Science 306, 876-879. (Pubitemid 39446997)
3. Ganem, N. J., Storchova, Z. and Pellman, D. (2007). Tetraploidy, aneuploidy and cancer. Curr. Opin. Genet. Dev. 17, 157-162.
4. Goggins, M., Schutte, M., Lu, J., Moskaluk, C. A., Weinstein, C. L., Petersen, G. M., Yeo, C. J., Jackson, C. E., Lynch, H. T., Hruban, R. H. et al. (1996). Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res. 56, 5360-5364. (Pubitemid 27011364)
5. Hucl, T., Rago, C., Gallmeier, E., Brody, J. R., Gorospe, M. and Kern, S. E. (2008). A syngeneic variance library for functional annotation of human variation: application to BRCA2. Cancer Res. 68, 5023-5030.
6. Jonsdottir, A. B., Vreeswijk, M. P., Wolterbeek, R., Devilee, P., Tanke, H. J., Eyfjord, J. E. and Szuhai, K. (2009). BRCA2 heterozygosity delays cytokinesis in primary human fibroblasts. Cell. Oncol. 31, 191-201.
7. Kuznetsov, S. G., Liu, P. and Sharan, S. K. (2008). Mouse embryonic stem cell-based functional assay to evaluate mutations in BRCA2. Nat. Med. 14, 875-881.
8. Lenart, P., Petronczki, M., Steegmaier, M., Di Fiore, B., Lipp, J. J., Hoffmann, M., Rettig, W. J., Kraut, N. and Peters, J. M. (2007). The small-molecule inhibitor BI 2536 reveals novel insights into mitotic roles of polo-like kinase 1. Curr. Biol. 17, 304-315. (Pubitemid 46251642)
9. Poser, I., Sarov, M., Hutchins, J. R., Heriche, J. K., Toyoda, Y., Pozniakovsky, A., Weigl, D., Nitzsche, A., Hegemann, B., Bird, A. W. et al. (2008). BAC TransgeneOmics: a high-throughput method for exploration of protein function in mammals. Nat. Methods 5, 409-415. (Pubitemid 351619099)
10. Sharan, S. K., Morimatsu, M., Albrecht, U., Lim, D. S., Regel, E., Dinh, C., Sands, A., Eichele, G., Hasty, P. and Bradley, A. (1997). Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature 386, 804-810. (Pubitemid 27181248)
11. Steigemann, P. and Gerlich, D. W. (2009). Cytokinetic abscission: cellular dynamics at the midbody. Trends Cell Biol. 19, 606-616.
12. Steigemann, P., Wurzenberger, C., Schmitz, M. H., Held, M., Guizetti, J., Maar, S. and Gerlich, D. W. (2009). Aurora B-mediated abscission checkpoint protects against tetraploidization. Cell 136, 473-484.
13. Straight, A. F., Cheung, A., Limouze, J., Chen, I., Westwood, N. J., Sellers, J. R. and Mitchison, T. J. (2003). Dissecting temporal and spatial control of cytokinesis with a myosin II Inhibitor. Science 299, 1743-1747. (Pubitemid 36337202)
14. Tarsounas, M., Davies, D. and West, S. C. (2003). BRCA2-dependent and independent formation of RAD51 nuclear foci. Oncogene 22, 1115-1123. (Pubitemid 36363377)
15. Thorslund, T. and West, S. C. (2007). BRCA2: a universal recombinase regulator. Oncogene 26, 7720-7730.
16. Tutt, A., Gabriel, A., Bertwistle, D., Connor, F., Paterson, H., Peacock, J., Ross, G. and Ashworth, A. (1999). Absence of Brca2 causes genome instability by chromosome breakage and loss associated with centrosome amplification. Curr. Biol. 9, 1107-1110. (Pubitemid 29504480)
17. Venkitaraman, A. R. (2002). Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108, 171-182. (Pubitemid 34161138)
18. Yu, V. P., Koehler, M., Steinlein, C., Schmid, M., Hanakahi, L. A., van Gool, A. J., West, S. C. and Venkitaraman, A. R. (2000). Gross chromosomal rearrangements and genetic exchange between nonhomologous chromosomes following BRCA2 inactivation. Genes Dev. 14, 1400-1406. (Pubitemid 30397083)